Swift Run Capital - DIFFUSION PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Swift Run Capital ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$17,000
+240.0%
20,000
+37.5%
0.03%
+385.7%
Q1 2020$5,000
-28.6%
14,5450.0%0.01%
-22.2%
Q4 2019$7,000
-74.1%
14,5450.0%0.01%
-64.0%
Q3 2019$27,000
-34.1%
14,5450.0%0.02%
-34.2%
Q2 2019$41,000
-24.1%
14,5450.0%0.04%
-24.0%
Q1 2019$54,000
+86.2%
14,5450.0%0.05%
+61.3%
Q4 2018$29,00014,5450.03%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Yu Fan 269,544$213,0000.35%
Southland Equity Partners LLC 12,030$9,5640.01%
Sugarloaf Wealth Management, LLC 15,750$13,0000.00%
Frontier Wealth Management LLC 25,000$20,0000.00%
Renaissance Technologies 2,832,739$2,252,0000.00%
UBS Group AG 5,999$5,0000.00%
IFP Advisors, Inc 0$00.00%
Squarepoint Ops LLC 17,984$14,0000.00%
TWO SIGMA INVESTMENTS, LP 106,341$85,0000.00%
OSAIC HOLDINGS, INC. 29,477$24,0000.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders